4.35
price down icon1.81%   -0.08
after-market Dopo l'orario di chiusura: 4.35
loading
Precedente Chiudi:
$4.43
Aprire:
$4.42
Volume 24 ore:
48,391
Relative Volume:
0.42
Capitalizzazione di mercato:
$37.58M
Reddito:
$140.46M
Utile/perdita netta:
$-146.34M
Rapporto P/E:
-3.4252
EPS:
-1.27
Flusso di cassa netto:
$-117.73M
1 W Prestazione:
+12.99%
1M Prestazione:
-3.12%
6M Prestazione:
-58.57%
1 anno Prestazione:
-69.80%
Intervallo 1D:
Value
$4.35
$4.60
Intervallo di 1 settimana:
Value
$3.85
$4.91
Portata 52W:
Value
$3.51
$16.95

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Name
Nome
Karyopharm Therapeutics Inc
Name
Telefono
617-658-0600
Name
Indirizzo
85 WELLS AVENUE, NEWTON, MA
Name
Dipendente
279
Name
Cinguettio
@Karyopharm
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
KPTI's Discussions on Twitter

Confronta KPTI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KPTI
Karyopharm Therapeutics Inc
4.35 41.99M 140.46M -146.34M -117.73M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-16 Downgrade H.C. Wainwright Buy → Neutral
2025-07-11 Ripresa H.C. Wainwright Buy
2023-01-19 Iniziato Piper Sandler Overweight
2022-11-04 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-02-09 Aggiornamento JP Morgan Underweight → Neutral
2021-11-19 Ripresa Morgan Stanley Equal-Weight
2021-08-06 Downgrade JP Morgan Overweight → Neutral
2021-08-06 Downgrade RBC Capital Mkts Outperform → Sector Perform
2021-08-06 Downgrade SVB Leerink Outperform → Mkt Perform
2020-07-02 Iniziato Morgan Stanley Overweight
2020-03-04 Iniziato Barclays Overweight
2020-01-17 Downgrade Wedbush Outperform → Neutral
2019-07-23 Aggiornamento JP Morgan Neutral → Overweight
2019-07-05 Reiterato H.C. Wainwright Buy
2019-07-05 Reiterato Robert W. Baird Outperform
2019-03-01 Downgrade JP Morgan Overweight → Neutral
2019-02-28 Reiterato BofA/Merrill Underperform
2019-02-27 Downgrade BofA/Merrill Neutral → Underperform
2019-01-03 Aggiornamento BofA/Merrill Underperform → Neutral
2018-12-03 Iniziato B. Riley FBR Buy
2018-11-09 Aggiornamento Wedbush Neutral → Outperform
2018-05-24 Downgrade Wedbush Outperform → Neutral
2018-04-02 Ripresa Leerink Partners Outperform
2017-11-15 Ripresa H.C. Wainwright Buy
2017-09-15 Iniziato RBC Capital Mkts Outperform
2016-09-08 Reiterato H.C. Wainwright Buy
2016-08-30 Aggiornamento Jefferies Hold → Buy
2016-08-18 Iniziato H.C. Wainwright Buy
2016-06-28 Iniziato Robert W. Baird Outperform
Mostra tutto

Karyopharm Therapeutics Inc Borsa (KPTI) Ultime notizie

pulisher
02:33 AM

What drives Karyopharm Therapeutics Inc. stock priceConsistently high returns - PrintWeekIndia

02:33 AM
pulisher
06:23 AM

Karyopharm Therapeutics Inc. Stock Analysis and ForecastFast-track wealth growth - PrintWeekIndia

06:23 AM
pulisher
04:35 AM

What analysts say about Karyopharm Therapeutics Inc. stockUnprecedented market success - Autocar Professional

04:35 AM
pulisher
Jul 24, 2025

How high can Karyopharm Therapeutics Inc. stock price go in 2025High-yield market plays - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Triple Refractory Multiple Myeloma Market Forecast 2032: - openPR.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Karyopharm Therapeutics Inc. a good long term investmentRapid wealth multiplication - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 22, 2025
pulisher
Jul 22, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress

Jul 22, 2025
pulisher
Jul 18, 2025

Will Karyopharm Therapeutics Inc. stock split in the near futureHigh Return Intraday Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

HC Wainwright & Co. Downgrades Karyopharm Therapeutics (KPTI) - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

H.C. Wainwright downgrades Karyopharm stock to Neutral amid financial concerns - Investing.com Canada

Jul 16, 2025
pulisher
Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025
pulisher
Jul 15, 2025

How Karyopharm Therapeutics Inc. stock performs during market volatilityTop Performing Low Risk Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Karyopharm Therapeutics Inc. stock price move sharplyROI Driven Alerts - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

Why Karyopharm Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Expert Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Newton biotech cuts over 50 jobs, and other biotech news - The Business Journals

Jul 15, 2025
pulisher
Jul 13, 2025

HC Wainwright Initiates Coverage on Karyopharm Therapeutics (NASDAQ:KPTI) - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Karyopharm Therapeutics: A Liquidity Crossroads with Little Room to Pivot - AInvest

Jul 12, 2025
pulisher
Jul 11, 2025

Karyopharm stock tumbles after disclosing failed financing talks By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Karyopharm Shares Slide After Financing Efforts Stall, Strategic Review Underway - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Karyopharm's Freefall: What's Driving the Collapse? - AInvest

Jul 11, 2025

Karyopharm Therapeutics Inc Azioni (KPTI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Karyopharm Therapeutics Inc Azioni (KPTI) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Paulson Richard A.
President and CEO
May 06 '25
Sale
7.12
236
1,680
82,503
Rangwala Reshma
EVP & Chief Medical Officer
Apr 23 '25
Sale
6.17
419
2,585
28,853
Paulson Richard A.
President and CEO
Apr 04 '25
Sale
3.74
245
916
82,739
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Mar 04 '25
Sale
6.29
3,445
21,669
34,314
Paulson Richard A.
President and CEO
Mar 04 '25
Sale
6.29
11,694
73,555
82,984
Rangwala Reshma
EVP & Chief Medical Officer
Mar 04 '25
Sale
6.29
3,587
22,562
29,272
Poulton Stuart
EVP, Chief Development Officer
Mar 04 '25
Sale
6.29
3,548
22,317
27,414
Mano Michael
SVP, General Counsel&Secretary
Mar 04 '25
Sale
6.29
2,793
17,568
21,047
Poulton Stuart
EVP, Chief Development Officer
Feb 18 '25
Sale
0.63
5,914
3,726
320,714
Paulson Richard A.
President and CEO
Feb 04 '25
Sale
0.65
4,099
2,664
1,120,158
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):